Mereo BioPharma (MREO) Interest & Investment Income (2023 - 2026)
Mereo BioPharma (MREO) reported Interest & Investment Income of $327000.0 for Q1 2026, down 50.38% year-over-year from $659000.0 in Q1 2025, and down 22.33% quarter-over-quarter from $421000.0 in Q4 2025.
Mereo BioPharma (MREO) Interest & Investment Income (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Interest & Investment Income data on file, last reported at $327000.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $327000.0, down 50.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 40.27% YoY), and the FY2025 annual result was $2.2 million, down 28.54% from the prior year.
- Interest & Investment Income retreated to $327000.0 in Q1 2026 per MREO's latest filing, from $421000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $983000.0 in Q3 2024 and troughed at $306000.0 in Q1 2023.
- A 4-year average of $590076.9 and a median of $589000.0 in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income soared 101.63% in 2024, then slumped 52.21% in 2025.
- A 4-year view of Interest & Investment Income shows it stood at $763000.0 in 2023, then climbed by 15.47% to $881000.0 in 2024, then tumbled by 52.21% to $421000.0 in 2025, then slipped by 22.33% to $327000.0 in 2026.
- Business Quant data shows MREO's Interest & Investment Income at $327000.0 in Q1 2026, $421000.0 in Q4 2025, and $504000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | 327,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 327,000.00 |
| Dec 31, 2025 | 421,000.00 |
| Sep 30, 2025 | 504,000.00 |
| Jun 30, 2025 | 589,000.00 |
| Mar 31, 2025 | 659,000.00 |
| Dec 31, 2024 | 881,000.00 |
| Sep 30, 2024 | 983,000.00 |
| Jun 30, 2024 | 559,000.00 |
| Mar 31, 2024 | 617,000.00 |
| Dec 31, 2023 | 763,000.00 |
| Sep 30, 2023 | 689,000.00 |
| Jun 30, 2023 | 373,000.00 |
| Mar 31, 2023 | 306,000.00 |